Vimarsana
Biggest News Aggregation in the World

Precertification Pilot News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precertification Pilot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precertification Pilot Today - Breaking & Trending Today

Pear Therapeutics, Inc.: Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst at ISPOR Europe - Vimarsana News

Pear Therapeutics, Inc.: Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst at ISPOR Europe

Somryst is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of chronic insomnia Analysis demonstrated potential per-patient cost reductions over 24 months of

Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder - Vimarsana News

Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Pear Therapeutics Reports First Quarter 2022 Financial Results - Vimarsana News

Pear Therapeutics Reports First Quarter 2022 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Pear Therapeutics Joins Epic App Orchard To Enable Clinicians To Monitor Prescription Digital Therapeutics - Vimarsana News

Pear Therapeutics Joins Epic App Orchard To Enable Clinicians To Monitor Prescription Digital Therapeutics

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs),...

Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results - Vimarsana News

Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com